Peripheral Arterial Disease Trial, Recruiting (NCT06274697)

Peripheral Arterial Disease Trial, Recruiting NCT06274697 Sponsor: University Hospital, Montpellier Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06274697 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are currently admitted to the Heart-Lung Unit at Montpellier University Hospital, for any medical reason
People who either have lower limb artery disease (a condition affecting blood flow in the legs) at any stage, or who do not have this condition at all
People who are 18 years of age or older

Who may not be able to join:

People who have a metal implant located near the area of the body where the trial device would be used
People who require special infection control or hygiene precautions during their hospital stay
People who are not covered by a French social security scheme
Women who are pregnant or breastfeeding, people who are unable to give their own consent, adults under legal protection, or people considered vulnerable (confirm with trial site)
People who are currently detained or restricted in their freedom by a court or government authority
People who do not wish to give their consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33467336279

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06274697

Sponsor: University Hospital, Montpellier

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

Trial contact: +33467336279

More information: https://clinicaltrials.gov/study/NCT06274697

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are currently admitted to the Heart-Lung Unit at Montpellier University Hospital, for any medical reason
People who either have lower limb artery disease (a condition affecting blood flow in the legs) at any stage, or who do not have this condition at all
People who are 18 years of age or older

Who may not be able to join:

People who have a metal implant located near the area of the body where the trial device would be used
People who require special infection control or hygiene precautions during their hospital stay
People who are not covered by a French social security scheme
Women who are pregnant or breastfeeding, people who are unable to give their own consent, adults under legal protection, or people considered vulnerable (confirm with trial site)
People who are currently detained or restricted in their freedom by a court or government authority
People who do not wish to give their consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Montpellier

Registry

ClinicalTrials.gov

Start date

2 April 2024

Est. completion

1 October 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Correlation of the two curve amplitudes (y) versus time (x) between the signal recording obtained by the CapMagic prototype on the radial artery and the pulsed echo-Doppler recording on the radial artery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov